Articles in Business

Lorillard Woes to Continue with Declining Cigarette Volumes - Analyst Blog

On Sep 30, 2014, we issued an updated research report on Lorillard Inc ( LO ). This cigarette maker reported second quarter 2014 results on Jul 30 wherein it delivered earnings of 84 cents per... Read >>

Wyndham Strives to Improve Traffic Amid Macro Concerns - Analyst Blog

On Sep 30, 2014, we issued an updated research report on Wyndham Worldwide Corporation ( WYN ). On Jul 24, the company posted strong second quarter 2014 results with earnings and revenue beating... Read >>

Tech Data Corp. (TECD) Continues to Thrive on Partnerships - Analyst Blog

Wholesale distributor of IT products, Tech Data Corp. ( TECD ) continues to thrive on partnerships as a means of broadening its product portfolio. To date, in fiscal 2014, the company has signed a... Read >>

ON Semiconductor, Transphorm Partner for GaN Products - Analyst Blog

ON Semiconductor ( ONNN ) recently entered into a strategic partnership with Transphorm, a company engaged in the development and marketing of modular power conversion products. Transphorm is also... Read >>

Is SunEdison (SUNE) Stock Worth Adding to Your Portfolio? - Analyst Blog

Shares of SunEdison, Inc. ( SUNE ) have shown phenomenal growth over the past year. Some of the recent optimism about the shares may be attributed to SunEdison's expansion in India, where it is... Read >>

Alibaba to Acquire 15% Stake in Shiji Information for $457M - Analyst Blog

Alibaba Group Holding Ltd.  ( BABA ), in its first big investment following its $25 billion record breaking IPO, is spending around $457 million to acquire a 15% stake in Beijing Shiji Information... Read >>

Martin Tillier

GoPro (GPRO) Dip Is A Classic Overreaction By The Market

Even during volatile times such as these, when a high profile stock is trading nearly 14 percent lower than the previous day’s close it is noteworthy. Such was the case with shares in GoPro (... Read >>

Progenics/Salix's Relistor Label Expanded in the U.S. - Analyst Blog

Regulatory decisions are highly awaited events in the pharma biotech sector. A positive decision may result in significant stock price appreciation. Earlier in the week, the FDA has approved Salix... Read >>

Exelon's (EXC) Stable Liquidity Aids Expansion Program - Analyst Blog

On Sep 26, we have issued an updated research report on Exelon Corporation ( EXC ). The utility provider's stable financial position, systematic investments in inorganic and organic growth... Read >>

AbbVie's (ABBV) Humira Gains Yet Another FDA Approval - Analyst Blog

AbbVie 's ( ABBV ) key growth engine is Humira. Sales of the company's flagship product, approved for multiple indications, had increased 10.7% to $10.7 billion in 2013. The company expects Humira... Read >>